OPRX OptimizeRx Corp.

NASDAQ
$8.72

OptimizeRx Corp. (OPRX) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +27.9% since its last earnings release on August 12, 2026.

OptimizeRx Beat Expectations, Reaffirms
Wednesday, August 12, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 4:00 PM ET
Earnings Whisper
-
vs $0.14 (GAAP)
Rev est $25.92M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $8.76

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About OptimizeRx Corp.

OptimizeRx Corp operates as a technology solutions company targeting the health care industry. The company provides technology solutions for connecting patients, physicians and pharmaceutical manufacturers.

Sector

Technology

Industry

Application Software

Held By 1 ETFs, by dollar flow